Type 2 Diabetes Mellitus Clinical Trial
Official title:
Alkaline Diet for Insulin Sensitivity
The purpose of this study is to test the effect of increasing the body pH acutely with an
alkaline medication (sodium bicarbonate, NaHCO3, sodibic) on glucose metabolism post meal in
non diabetic subjects with normal renal function.
The investigators aim to determine whether there is an acute reduction in venous blood pH
following a typical Western-style (high acid load) breakfast in healthy men and women, and
whether this effect is attenuated by the concurrent administration of an alkaline
medication. The effect on glucose metabolism, hunger/satiety and arterial stiffness post
meal will be assessed.
The aim of the study is to test the effect of increasing the body pH acutely with an alkali
(NaHCO3) prior to a high acid load meal on glucose metabolism in non-diabetic men and women.
This is a double-blind placebo-controlled randomised study with a crossover design.
Study Procedures:
Two (2) meal studies will be performed 1 to 2 weeks apart. Studies will include collecting
fasting blood to assess circulating glucose, insulin, C-peptide, free fatty acids,
glucagon-like peptide-1, acid/base markers, including electrolytes (EUC) and venous blood
pH. Participants will then be either administered sodibic (1680 mg) or matching placebo and
a standardised Western style/high acid load meal. Investigators and participants will be
blinded to the intervention. Blood will be drawn every 15 min in the first hour and then
every 30 min for 3 hours in total. Arterial stiffness and appetite score will be evaluated
at ½ h intervals.
Sample size: 30
sample size calculation: To detect a difference in area under the curve (AUC) of venous
blood pH with a paired crossover design, 32 individuals will be required with statistical
power 1-β>0.8 (allowing for drop-out).
statistical considerations: Differences between AUC of outcome measures post sodium
bicarbonate vs. placebo will be tested using paired t-tests. Two-way repeated measure ANOVA
tests will be conducted to assess differences in the response to the meal with sodium
bicarbonate vs. placebo.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02771093 -
An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes Mellitus
|
Phase 4 | |
Completed |
NCT02545842 -
Assessment Study of Three Different Fasting Plasma Glucose Targets in Chinese Patients With Type 2 Diabetes Mellitus (BEYOND III/FPG GOAL)
|
Phase 4 | |
Recruiting |
NCT03436212 -
Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Insulin Pump.
|
N/A | |
Completed |
NCT03244800 -
A Study to Investigate Different Doses of 0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.
|
Phase 2 | |
Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
Withdrawn |
NCT02769091 -
A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 Diabetes
|
Phase 2 | |
Recruiting |
NCT06065540 -
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
|
Phase 3 | |
Recruiting |
NCT05008276 -
Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
|
||
Completed |
NCT04091373 -
A Study Investigating the Pharmacokinetics of a Single Dose Administration of Cotadutide
|
Phase 1 | |
Completed |
NCT03296800 -
Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT06212778 -
Relationship Between Nutritional Status, Hand Grip Strength, and Fatigue in Hospitalized Older Adults With Type 2 Diabetes Mellitus.
|
||
Completed |
NCT05979519 -
Fresh Carts for Mom's to Improve Food Security and Glucose Management
|
N/A | |
Recruiting |
NCT05579314 -
XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
Completed |
NCT03859934 -
Metabolic Effects of Melatonin Treatment
|
Phase 1 | |
Terminated |
NCT03684642 -
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
|
Phase 3 | |
Completed |
NCT03248401 -
Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes
|
Phase 4 | |
Completed |
NCT03644134 -
A Personalized Intervention to Manage Physiological Stress and Improve Sleep Patterns
|
N/A | |
Completed |
NCT05295160 -
Fasting-Associated Immune-metabolic Remission of Diabetes
|
N/A | |
Completed |
NCT02836873 -
Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
|
Phase 3 | |
Completed |
NCT02252224 -
Forxiga (Dapagliflozin) Regulatory Postmarketing Surveillance
|